Skip to content
Clinical Trials – home
RomaniaBack to Romania

Clinical trials in Bistrița

7 clinical trials in Bistrița, Romania. Every trial is listed in the EU Clinical Trials Register and updated daily.

RomaniaOur site in RomaniaStudii.Clinice.ro(opens in a new tab)
Bistrița at a glance
7
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

7 trials in Bistrița

Open in trial search

Psoriasis

Recruiting

Long-term safety study of deucravacitinib compared to ustekinumab in adults with moderate to severe plaque psoriasis

Registered drugNo placebo
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Deucravacitinib
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company

Efficacy and safety of weekly subcutaneous zenagamtide versus placebo in adults with type 2 diabetes not controlled by diet and exercise

Investigational
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Zenagamtide
  • Sponsor:Novo Nordisk A/S

Type 2 diabetes mellitus+2

Not yet recruiting

A Study of Zenagamtide in Adults With Overweight or Obesity and Type 2 Diabetes

Investigational
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Zenagamtide
  • Sponsor:Novo Nordisk A/S

Hereditary haemochromatosis

Not yet recruiting

A study to evaluate the effectiveness and safety of vamifeport in adults with hereditary hemochromatosis

Investigational
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Vamifeport trihydrochloride
  • Sponsor:CSL Behring LLC

Type 2 diabetes mellitus+2

Not recruiting

Zenagamtide Compared with Semaglutide in Adults with Overweight or Obesity and Type 2 Diabetes

Investigational
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Semaglutide
  • Sponsor:Novo Nordisk A/S

A study comparing cagrilintide and semaglutide combination to semaglutide, cagrilintide, and placebo in adults with type 2 diabetes on metformin

Registered drug
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Cagrilintide
  • Sponsor:Novo Nordisk A/S

Breast cancer+1

Not recruiting

Study of Izalontamab Brengitecan Compared to Standard Chemotherapy in Untreated Triple-negative or ER-low, HER2-negative Breast Cancer Patients Not Eligible for Anti-PD1/PD-L1 Treatment

Registered drugNo placebo
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company

Other cities in Romania

The busiest research cities in the country

All 63 cities in Romania

Clinical research in Bistrița

What the registry says about research in the country

01 Neoplasms

Researchers in Bistrița are conducting a trial that examines a novel antibody‑drug conjugate for patients with triple-negative breast cancer and other HER2‑negative tumors, aiming to identify the optimal dose and compare its effectiveness against standard chemotherapy options.

  • Evaluation of a novel antibody‑drug conjugate
  • Comparison with standard chemotherapy regimens
  • Focus on patients with inoperable or metastatic disease
  • Assessment of safety and efficacy

The study is actively recruiting, offering participants access to cutting‑edge treatment while contributing to improved therapeutic strategies for aggressive breast cancer subtypes.

02 Congenital, Hereditary, and Neonatal Diseases and Abnormalities

An ongoing investigation in Bistrița focuses on adults with hereditary hemochromatosis caused by HFE gene mutations, testing the iron‑chelator vamifeport and measuring its impact on MRI‑based liver iron concentration.

  • Evaluation of iron reduction therapy
  • Use of MRI to monitor liver iron levels
  • Inclusion of adult participants with HFE‑related disease
  • Safety profile assessment

Recruitment is open, and the trial seeks to improve disease management by providing a targeted approach to reduce hepatic iron overload.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.